Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NSCLC: primary tumor size--radiation dose-related accelerated, twice daily radiotherapy by target splitting, preceded by 2 cycles of chemotherapy--first results of a prospective study.
Wurstbauer K, Deutschmann H, Kopp P, Kranzinger M, Merz F, Nairz O, Studnicka M, Sedlmayer F. Wurstbauer K, et al. Among authors: sedlmayer f. Strahlenther Onkol. 2007 Dec;183 Spec No 2:38-40. doi: 10.1007/s00066-007-2015-4. Strahlenther Onkol. 2007. PMID: 18167008 No abstract available.
A dosimetric comparison of IORT techniques in limited-stage breast cancer.
Nairz O, Deutschmann H, Kopp M, Wurstbauer K, Kametriser G, Fastner G, Merz F, Reitsamer R, Menzel C, Sedlmayer F. Nairz O, et al. Among authors: sedlmayer f. Strahlenther Onkol. 2006 Jun;182(6):342-8. doi: 10.1007/s00066-006-1580-2. Strahlenther Onkol. 2006. PMID: 16703290
IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: results of an ISIORT pooled analysis.
Sedlmayer F, Fastner G, Merz F, Deutschmann H, Reitsamer R, Menzel C, Ciabattoni A, Petrucci A, Hager E, Willich N, Orecchia R, Valentini V; International Society of Intraoperative Radiotherapy. Sedlmayer F, et al. Strahlenther Onkol. 2007 Dec;183 Spec No 2:32-4. doi: 10.1007/s00066-007-2013-6. Strahlenther Onkol. 2007. PMID: 18167006 No abstract available.
Nonresected non-small-cell lung cancer in Stages I through IIIB: accelerated, twice-daily, high-dose radiotherapy--a prospective Phase I/II trial with long-term follow-up.
Wurstbauer K, Deutschmann H, Kopp P, Kranzinger M, Merz F, Nairz O, Studnicka M, Sedlmayer F. Wurstbauer K, et al. Among authors: sedlmayer f. Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1345-51. doi: 10.1016/j.ijrobp.2009.06.060. Epub 2009 Nov 10. Int J Radiat Oncol Biol Phys. 2010. PMID: 19910140 Clinical Trial.
DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume.
Wurstbauer K, Deutschmann H, Dagn K, Kopp P, Zehentmayr F, Lamprecht B, Porsch P, Wegleitner B, Studnicka M, Sedlmayer F. Wurstbauer K, et al. Among authors: sedlmayer f. Radiat Oncol. 2013 Mar 5;8:49. doi: 10.1186/1748-717X-8-49. Radiat Oncol. 2013. PMID: 23497555 Free PMC article.
184 results